Pharmaceuticals - South Korea

  • South Korea
  • The South Korean Pharmaceuticals market is expected to witness significant growth in the coming years.
  • According to projections, the market's revenue is set to reach US$13.31bn in 2024.
  • Among the various markets, Oncology Drugs is expected to be the largest, with a projected market volume of US$2.32bn in the same year.
  • This indicates the growing demand for oncology treatments in South Korea.
  • Moreover, the Pharmaceuticals market in South Korea is anticipated to display a compound annual growth rate (CAGR) of 5.11% between 2024 and 2029.
  • This steady growth trajectory is expected to result in a market volume of US$17.08bn by 2029.
  • When compared globally, it is worth mentioning that United States is projected to generate the highest revenue in the Pharmaceuticals market.
  • In 2024, United States is estimated to generate a staggering US$630.30bn in revenue.
  • This highlights the strong market presence and dominance of the United States in the global pharmaceutical industry.
  • In conclusion, the Pharmaceuticals market in South Korea is poised for substantial growth, driven by factors such as the increasing demand for oncology drugs.
  • However, it is important to keep in mind the global context, with United States leading in terms of revenue generation.
  • South Korea is witnessing a surge in the research and development of innovative pharmaceuticals, leading to advancements in healthcare and increased international collaboration.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmaceuticals market in South Korea has been experiencing substantial growth in recent years.

Customer preferences:
South Korean consumers are increasingly interested in preventative healthcare, leading to a rise in demand for over-the-counter medications and supplements. Additionally, the aging population has created a higher demand for prescription medications.

Trends in the market:
One trend in the South Korean Pharmaceuticals market is the increasing use of technology in healthcare. This includes telemedicine and mobile health apps, which allow patients to receive medical advice and prescriptions without leaving their homes. Another trend is the rise of biosimilars, which are similar but not identical versions of biologic drugs. Biosimilars are becoming more popular due to their lower cost compared to the original biologic drugs.

Local special circumstances:
South Korea has a strong government-led healthcare system, with the government playing a significant role in regulating drug prices and approving new drugs. Additionally, cultural beliefs around healthcare may differ from other countries, with a greater emphasis on traditional medicine and natural remedies.

Underlying macroeconomic factors:
The South Korean economy has been growing steadily in recent years, with a focus on innovation and technology. This has led to increased investment in the healthcare sector and the development of new drugs and treatments. Additionally, the government has implemented policies to encourage research and development in the pharmaceutical industry. However, the market is also facing challenges such as increasing competition and regulatory hurdles.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Next generation therapy
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)